(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Neurociencias > Neurofarmacología y conducta > DA - CIMA - Neurociencias - Neurofarmacología y conducta - Artículos de Revista >

Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease
Autor(es) : Mateos, L. (Laura)
Ismail, M.A. (M. A.)
Gil-Bea, F.J. (Francisco J.)
Leoni, V. (Valerio)
Winblad, B. (Bengt)
Björkhem, I. (Ingermar)
Cedazo-Minguez, A. (Ángel)
Palabras clave : Angiotensin I/II
angiotensinogen
cholesterol
4-hydroxycholesterol
mild cognitive impairment
neurodegeneration
Fecha incorporación: 2011
Editorial : IOS Press
Versión del editor: http://dx.doi.org/10.3233/JAD-2011-101512
ISSN: 1387-2877
Cita: Mateos L, Ismail MA, Gil-Bea FJ, Leoni V, Winblad B, Björkhem I, et al. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease. J Alzheimers Dis 2011;24(4):669-679.
Resumen
In spite of the fact that cholesterol does not pass the blood-brain barrier, hypercholesterolemia has been linked to increase Alzheimer's disease (AD) risk. Hypertension is another risk factor and angiotensin converting enzyme (ACE) activity is known to be increased in AD. Furthermore, a lower incidence of AD has been reported in patients taking anti-hypertensive drugs. Here we show that the levels of angiotensinogen (AGT) and ACE are increased in the cerebrospinal fluid (CSF) of patients with mild cognitive impairment and AD. Moreover, we show ACE activity in the CSF to be positively correlated with both plasma and CSF levels of 27-hydroxycholesterol (27-OH), an oxysterol known to pass through the BBB and taken up from the circulation by the brain. In addition, treatment of rat primary neurons, astrocytes, and human neuroblastoma cells with 27-OH resulted in increased production of AGT. Our results demonstrate that upregulation of renin-angiotensin system (RAS) in AD brains occurs not only at the enzymatic level (ACE) but also at the substrate level (AGT). The possibility that 27-OH is part of a mechanism linking hypercholesterolemia with increased brain RAS activity and increased AD risk is discussed.
Enlace permanente: http://hdl.handle.net/10171/19574
Aparece en las colecciones: DA - CIMA - Neurociencias - Neurofarmacología y conducta - Artículos de Revista

Ficheros en este registro:
Fichero:  fulltext.pdf
Descripción: 
Tamaño:  278,9 kB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.